Nestle Will Sweeten Its Skin-Care Offering With Valeant Derm Brands
This article was originally published in The Rose Sheet
Executive Summary
Swiss food and beverage company Nestle SA is growing its stake in skin care, particularly in North America, with its pending $1.4 billion acquisition of five aesthetic dermatology brands from Valeant Pharmaceuticals International Inc., which would be folded into the firm’s Nestle Skin Care Health division. Subject to regulatory approval, the deal demonstrates the firm’s new commitment to health and wellness, says analyst.
You may also be interested in...
EU Parliament Backs Cosmetic Microplastic Ban; Rite Aid Unveils Chemicals Policy; News In Brief
Rite Aid joins the growing club of retailers with chemicals policies; EU lawmakers vote in support of a proposed ban on cosmetic microplastic use; Monat continues to battle class action litigation; Nestle is exploring strategic options for its Skin Health business.
L’Oreal Buys Back Shares From Nestle, Sells Galderma Stake
To finance a deal to purchase more than €6 billion of its own shares back from Nestle SA, L’Oreal SA has given up its half of skin-care company Galderma.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.